Citius Pharmaceuticals, Inc. financial data

Symbol
CTXR on Nasdaq
Industry
Pharmaceutical Preparations
Location
11 Commerce Drive, 1 St Floor, Cranford, NJ
State of incorporation
NV
Fiscal year end
September 30
Former names
Trail One, Inc. (to 9/18/2014), TrailOne, Inc. (to 1/21/2011)
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 570 % -26.3%
Debt-to-equity 13.4 % +15.2%
Return On Equity -44.7 % -44%
Return On Assets -39.4 % -41.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 181M shares +13.8%
Common Stock, Shares, Outstanding 181M shares +13.8%
Entity Public Float 157M USD -34.6%
Common Stock, Value, Issued 181K USD +13.8%
Weighted Average Number of Shares Outstanding, Basic 174M shares +13.1%
Weighted Average Number of Shares Outstanding, Diluted 174M shares +13.1%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 11.9M USD -24.8%
General and Administrative Expense 16.9M USD +22.2%
Operating Income (Loss) -41.1M USD -20.2%
Nonoperating Income (Expense) 3.35M USD -39.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -37.7M USD -27.5%
Income Tax Expense (Benefit) 576K USD 0%
Net Income (Loss) Attributable to Parent -38.3M USD -25.2%
Earnings Per Share, Basic -0.21 USD/shares 0%
Earnings Per Share, Diluted -0.21 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 17.9M USD -46.2%
Assets, Current 28M USD -31.9%
Property, Plant and Equipment, Net 275 USD -89.6%
Operating Lease, Right-of-Use Asset 300K USD -40.5%
Goodwill 9.35M USD 0%
Assets 97.1M USD -12.1%
Accounts Payable, Current 1.66M USD -46%
Employee-related Liabilities, Current 1.7M USD +6.06%
Accrued Liabilities, Current 550K USD -38.3%
Liabilities, Current 4.15M USD -28.3%
Deferred Income Tax Liabilities, Net 6.57M USD +9.61%
Operating Lease, Liability, Noncurrent 84.4K USD -73.6%
Liabilities 10.8M USD -10.7%
Retained Earnings (Accumulated Deficit) -191M USD -25.1%
Stockholders' Equity Attributable to Parent 85.7M USD -12.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 86.3M USD -12.2%
Liabilities and Equity 97.1M USD -12.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.14M USD -27.2%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 181M shares +13.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 17.9M USD -46.2%
Deferred Tax Assets, Valuation Allowance 4.98M USD -53.7%
Operating Lease, Liability 320K USD -39.9%
Depreciation 578 USD -20.8%
Lessee, Operating Lease, Liability, to be Paid 339K USD
Operating Lease, Liability, Current 236K USD +10.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 21.5K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 254K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) 144K USD 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 18.5K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 21.5K USD
Deferred Tax Assets, Operating Loss Carryforwards 35M USD +0.89%
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 276M USD +10.5%
Share-based Payment Arrangement, Expense 1.17M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%